Midazolam and Dexmedetomidine Affect Neuroglioma and Lung Carcinoma Cell Biology In Vitro and In Vivo

Conclusions Midazolam possesses antitumorigenic properties partly mediated by the peripheral benzodiazepine receptor, whereas dexmedetomidine promotes cancer cell survival through signalingvia the α2-adrenoceptor in lung carcinoma and neuroglioma cells.

Source: Anesthesiology - October 16, 2018 Category: Anesthesiology Source Type: research